Skip to main content
. 2021 Jul 31;4(3):ooab050. doi: 10.1093/jamiaopen/ooab050

Table 3.

Adherence to medication changes and adverse events in 30 days post-discharge, by treatment group

Proportion of medication changes adhered to, n/N (%)
Medication change Overall Intervention Control
All changes 208/258 (80.6%) 103/123 (83.7%) 105/135 (77.8%)
 New medicationsa 77/115 (67.0%) 40/55 (72.7%) 37/60 (61.7%)
 Discontinued medicationsa 93/99 (93.9%) 43/46 (93.5%) 50/53 (94.3%)
 Dose changesb 38/44 (86.4%) 20/22 (90.9%) 18/22 (81.8%)

Number of patients (%) experiencing adverse events

Adverse event Overall (N = 49) Intervention (N = 23) Control (N = 26)

ED visit or hospital readmission 13 (26.5%) 6 (26.1%) 7 (26.9%)
 ED visit 10 (20.4%) 5 (21.7%) 5 (19.2%)
 Hospital readmission 6 (12.2%) 2 (8.7%) 4 (15.4%)

Abbreviations: ED: Emergency Department.

a

Adherence was assessed for new and discontinued medications that are covered by the RAMQ and, in the case of new medications, for those not prescribed “as needed”.

b

Adherence was assessed for dose changes that were dispensed in the 30 days following hospital discharge.